Refine
Estimated Years UndatedClear
6,022 results foundRefine Search
Position statement by MedicalMountains GmbH on the proposal for a restriction on per- and polyfluoroalkyl substances (PFASs) www.medicalmountains.de POSITION STATEMENT ( MedicalMountains MED ALLIANCE BW Contact: MedicalMountains GmbH Katharinenstrasse 2 D-78532 Tuttlingen Germany Julia Steckeler CEO @medicalmountains.de Phone +49 7461 969721-2 Meinrad Kempf Project manager M@medicalmountains.de Phone +49 7461 969721-8 www.medicalmountains.de 1 Contents 1.
refid# qadzKeJ3L6YJBE0YKKGnBpm6x48 pages
ARRRE -- 3.23] | 413 .
refid# ZnK32LX3G0Oe24bzjp5GQ2KyV16 pages
ARR -- 3266 3 : AR2AG _326 7 REPORT ON MUTAGENICITY TEST RESULTS USING MICROORGANISMS I ] Nomenclature of novel N 1 chemical substance (by a ag win TUPAC nomenclature) [Oername 1 Structure or empirical | not certain) L_8 | A Fl Pmoam roc |7 [|1 sLoetmNoi.ovfineovnee | _--Y foa n. -- " cam =| usedint|es Ret m | CAS No.
refid# JJBj9JKaEb5eBG4Be02VxwMn615 pages
Hu ^ AR226-3338 FINAL REPORT Bioaccumulationtest ofPwftooroalfeylcarboKyliaccid (C=7-'13) (Thistest i$ perfbrmed using Perfluorooctanoic acad (Test substance nuniba- K-l 519)] in carp (T&slNo.51519) Kuruae Laboraioiv Chemicals Evaluation and "Research Institute, Japan 55519 STATEMENT Sponsor Title Testnumber Kurume Laboratory Chemicals Evaluanon and Research Institute, Japan Ministry of International Trade and Industry Bloaccaimulatinn test ofPerflnnrnalkylcarhoxync acid (C=7-13) {This test is performedusing Pafluorooclanoic. add (Test substance nuinber K-l 519)]in carp 51519 J, the-unricrs!
refid# NE9g272Lmr7aVr6nE10e55DwV74 pages
AR226-3347 Analytical challenges in determination of Telo Alcohol and Telomer-derived fluorosurfactan polymers4n biological and environmental ma Bogdan Szostek^^lteith B.
refid# KR1KrdroVDna8k095epL3BOkw16 pages
Fluoropolymers and Fluoropolyethers: Critical Industrial Uses Emmission Control and Abatement and End of Life Management Contents 1.
refid# pB1ZdZ9ovYYZ8eYRX5zXkDBja43 pages
refid# O1d8kKy1EQqmG1bpdw6Opp6RM2 pages
p T D SE FINAL REPORT PROTOCOL 418-008 COMBINED ORAL (GAVAGE) FERTILITY, DEVELOPMENTAL PERINATAUPOSTNATAL REPRODUCTION TOXICITY STUDY IN RATS AND OF PFOS SPONSOR'S STUDY NUMBER: 6295.9 FINAL REPORT DATE: 10 JUNE 1999 PROTOCOL 418-008 COMBINED ORAL (GAVAGE) FERTILITY,DEVELOPMENTAL AND PERINATAUPOSTNATAL REPRODUCTION TOXICITY STUDY OF PFOS IN RATS SPONSOR'S STUDY NUMBER: 6295.9 TABLE OF CONTENTS SUBJECT 1.
refid# bBQZE2KGJNKge0531eMD1J093646 pages
litigation.
refid# byxJ3o7gZ750Gew51egBdnG0Z2 pages
refid# O1z3mejYbwKoXY71673VnwLDp1 page
Temp.
refid# ppvmd0NE7752Mx3eRYeDrjByj3 pages
WAAZLCMCN 3301 KINSMAN BLVD.
refid# aBZ87Bd9OyLE2QQynvgXg0pXe50 pages
Der Markt fr Medizintechnik Marktzahlen und Fakten Manfred C.
refid# G6oBKdZzGLLOgprXM3K8poy2730 pages
ff AR22-E SHH2 46 --- 000408 |!
refid# evNpag0NrrGDy35veL6pYkk8g2 pages
KION GROUP Page 1 KION GROUP do STILL S.A.U.
refid# 8OzGa07zYzGDa8okbp1GVYZ6e8 pages